Rodent models of nephropathy associated with type II diabetes

Journal of Nephrology

Volumn 12, Issue 3, 1999, Pages 159-172

  Janssen, Ulf ^a   Phillips, Aled O ^b   Floege, Jürgen ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Cardiff Royal Infirmary   (United Kingdom)

Author keywords

Animal models; Diabetes mellitus; GK rat; Hyperglycemia; Mesangial cells; Podocytes; Zucker rat

Indexed keywords

GLIPIZIDE; GLYCOSAMINOGLYCAN; IMMUNOGLOBULIN M; INSULIN; METFORMIN; PROTEIN KINASE C;

ANIMAL MODEL; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; EXPERIMENTAL DIABETES MELLITUS; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPOINSULINEMIA; KIDNEY FAILURE; MESANGIUM CELL; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PODOCYTE; PROTEINURIA; RAT; REVIEW; RODENT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0032777587     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (160)

1. Port FK. Worldwide demographics and future trends in endstage renal disease. Kidney Int 1993; 41: S4-7.
2. Pirson Y. The diabetic patient with ESRD: How to select the modality of renal replacement. Nephrol Dial Transplant 1996; 11: 1511-3.
3. The United States Renal Data System: USRDS Annual Data Report. Bethesda, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995.
4. Suzuki Y, Arakawa M. The treatment of the uraemic diabetic. Are we doing enough? A view from Japan. Fumitake Gejyo Collaborate Study Group. Nephrol Dial Transplant 1995; 10 (Suppl 7): 47-55.
5. Raine E. The rising tide of diabetic nephropathy: The warning before the flood? Nephrol Dial Transplant 1995; 10: 460-1.
6. Lippert J, Ritz E, Schwarzbeck A, Schneider P. The rising tide of endstage renal failure from diabetic nephropathy type II: An epidemiological analysis. Nephrol Dial Transplant 1995; 10: 462-7.
7. Vora JP, Dolben J, Dean JD, Thomas D, Williams JD, Owens DR, Peters JR. Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus. Kidney Int 1992; 41: 829-55.
8. Palmisano JJ, Lebovitz HE. Renal function in black Americans with type II diabetes. J Diabetes Complications 1989; 3: 40-4.
9. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC. Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984; 74: 1143-55.
10. Wiseman MJ, Saunders AJ, Keen H, Viverti G. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 1985; 312: 617-21.
11. Schmidt K, Pesce C, liu Q, Nelson RG, Bennett PH, Karnitschnig H, Striker LJ, Striker GE. Large glomerular size in Pima Indians: Lack of change with diabetic nephropathy. J Am Soc Nephrol 1992; 3: 229-35.
12. Seymour AE. Glomerular disease in whites versus Australian aboriginals: 'Last of a race in ruin.' Nephrol Dial Transplant 1995; 10: 769-70.
13. Schmitz A, Hansen HH, Christensen T. Kidney function in newly diagnosed type 2 (non-insulin-dependent) diabetic patients, before and during treatment. Diabetologia 1989; 32: 434-9.
14. Deckert T, Kofoed-Enevoldsen A, Vidal P, Norgaard K, Andearsen HB, Feldt-Rasmussen B. Size-and charge selectivity of glomerular filtration in type I (insulin-dependent) diabetic patients with and without albuminuria. Diabetologia 1993; 36: 244-51.
15. Wahl P, Deppermann D, Hasslacher C. Biochemistry of glomerular basement membrane of the normal and diabetic human. Kidney Int 1982; 21: 744-9.
16. Myers BD, Nelson RG, Williams GW, Bennet PH, Hardy SA, Berg RL, Loon N, Knowler WC, Mitch WE. Glomerular function in Pima Indians with non-insulin-dependent diabetes mellitus of recent onset. J Clin Invest 1991; 8: 524-30.
17. Tamsma JT, Van DB, Bruijn JA, Assmann KJ, Weening JJ, Berden JH, Wieslander J, Schrama E, Hermans J, Veerkamp JH. Expression of glomerular extracellular matrix components in human diabetic nephropathy: Decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 1994; 37: 313-20.
18. Standl E, Stiegler H. Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the greater Munich area. Diabetologia 1993; 36: 1017-20.
19. Anonymous. UK Prospective Diabetes Study (UKPDS). X. Urinary albumin excretion over 3 years in diet-treated type 2 (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycemia and hypertriglyceridaemia. Diabetologia 1993; 36: 1021-9.
20. Anonymous. UK Prospective Diabetes Study (UKPDS). IX. Relationships of urinary albumin and N-acetylglucosaminidase to glycemia and hypertension at diagnosis of type 2 (non-insulin-dependent) diabetes mellitus and after 3 months diet therapy. Diabetologia 1993; 36: 835-42.
21. Keller CK Bergis KH, Fliser D, Ritz E. Renal findings in patients with short-term type 2 diabetes.J Am Soc Nephrol 1996; 7: 2627-35.
22. Knowler WC, Kunzelman CL. Population comparison of the frequency of nephropathy. In: Mogensen CE, ed. The Kidney and Hypertension in Diabetes Mellitus. Boston: Martinus Nijhoff Publishing, 1988; p 25.
23. Kunzelman CL, Knowler WC, Petitt DJ, Bennett PH. Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians. Kidney Int 1989; 35: 681-7.
24. Hasslacher C, Ritz E, Wahl P, Michael C. Similar risks of nephropathy in patients with type I or type II diabetes mellitus. Nephrol Dial Transplant 1989; 4: 859-63.
25. Schmitz A, Vaeth M. Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabetes Med 1988; 5: 126-34.
26. Gall MA, Nielsen FS, Smitz UM, Parving HH. The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 1993; 36: 1071-8.
27. Parving HH, Gall MA, Skott P, Jorgensen HE, Lokkegaard H, Jorgensen F, Nielsen B, Larsen S. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 1992; 41: 758-62.
28. Marshall SM, Alberti KG. Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes. Q J Med 1989; 70: 61-71.
29. Schwartz MM, Lewis EJ, Leonard-Martin TC. Renal clinicopathology of type II diabetes mellitus (DM). J Am Soc Nephrol 1996; 7: 1364 [Abstract].
30. Hayashi H, Karasawa R, Inn H, Saitou T, Ueno M, Nishi S, Suzuki Y, Ogino S, Maruyama Y, Kouda Y, Arakawa M. An electron microscopic study of glomeruli in Japanese patients with non-insulin dependent diabetes mellitus. Kidney Int 1992; 41: 749-57.
31. Furuta T, Saito T, Ootaka T, SomaJ, Obara K, Keishi A, Yohinaga K The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis 1993; 21: 480-5.
32. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997; 15: 342-8.
33. Kimmelstiel P, Wilson C. Intercapillary lesions in the glomeruli of the kidney. Am J Pathol 1936; 12: 83-97.
34. Gambara V, Mecca G, Remuzzi G, Bertani T. Heterogenous nature of renal lesions in type II diabetes. J Am Soc Nephrol 1993; 3: 1458-66.
35. Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F, Muollo B, Sambataro M, Abaterusso C, Baggio B, Crepaldi G, Nosadini R. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 1996; 39, 1569-76.
36. Anonymous. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risks of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-53.
37. Anonymous. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 854-65.
38. Greene DA, Lattimer SA, Sima AA. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987; 316: 599-606.
39. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-21.
40. K. Anawar YS, Rosenzweig LJ, Linker A, Jakubowski ML. Decreased de novo synthesis of glomerular proteoglycans in diabetes: Biochemical and autoradiographic evidence. Proc Natl Acad Sci USA 1983; 80: 2272-7.
41. Rohrbach R. Reduced content and abnormal distribution of anionic sites (acid proteoglycans) in the diabetic glomerular basement membrane. Virchow's Arch 1986; 51: 127-35.
42. Rohrbach DH, Hassell JR, Kleinman HK, Martin GR. Alterations in the basement membrane (heparan sulfate) proteoglycan in diabetic mice. Diabetes 1982; 31: 185-8.
43. Larkins RG, Dunlop ME. The link between hyperglycemia and diabetic nephropathy. Diabetologia 1992; 35: 499-504.
44. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell S-E, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener PE, King GL. Amelioration of vascular dysfunction in diabetic rats by an oral PKC b inhibitor. Science 1996; 272: 728-31.
45. Phillips AO, Steadman R, Topley N, Williams JD. Elevated D-glucose concentrations modulate TGF-β 1 synthesis by human cultured proximal tubular cells. The permissive role of platelet-derived growth factor. Am J Pathol 1995; 147: 362-74.
46. Phillips AO, Topley N, Steadman R, Morrisey K, Williams JD. Induction of TGF-β 1 synthesis in D-glucose primed human proximal tubular cells by IL-1 β and TNF α. Kidney Int 1996; 50: 1546-54.
47. Nelson RG, Pettitt DJ, Baird HR, Charles MA, Liu QZ, Bennett PH, Knowler WC. Pre-diabetic blood pressure predicts urinary albumin excretion after the onset of type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1993; 36: 998-1001.
48. Strojek K, Grzeszczak W, Morawin E, Adamski M, Lack AB, Rudzki H, Schmidt S, Keller C, Ritz E. Nephropathy of type II diabetes: Evidence for hereditary factors. Kidney Int 1997; 51: 1602-7.
49. Iberti GC, Earle K. Predisposition to essential hypertension and the development of diabetic nephropathy. J Am Soc Nephrol 1992; 3 (Suppl 1): S27-33.
50. Stern MP. Diabetes and cardivascular disease: The 'common soil' hypothesis. Diabetes 1995; 44: 369-74.
51. Marquie G, Duhault J, Jacotot B. Diabetes mellitus in sand rats (Psammomys obesus). Metabolic pattern during development of the diabetic syndrome. Diabetes 1984; 33: 438-43.
52. Orci L, Stauffacher W, Amherdt M, Pictet R, Renold AE, Rouiller Ch. The kidney of spiny mouse (Acomys cahirinus): electron microscopy of glomerular changes associated with aging and tubular glycogen accumulation during hyperglycemia. Diabetologia 1970; 6: 342-55.
53. Wise PH, Weir BJ, HimeJM, Forrest E. The diabetic syndrome in the Tuco-Tuco (Ctenomys talarum). Diabetologia 1972; 8: 165-72.
54. Kondo K, Nozawa K, Tomida T, Ezaki K. Inbred strains resulting from Japanese mice. Bull Exp Animals 1957; 6: 107-12.
55. Nakamura M. A diabetic strain of the mouse. Proc Japan Acad 1962; 38: 348-52.
56. Nakamura N, Yamada K. Studies on a diabetic (KK) strain of the mouse. Diabetologia 1967; 3: 212-21.
57. Camerini-Davalos RA, Oppermann W, Mittl R, Ehrenreich T. Studies of vascular and other lesions in KK mice. Diabetologia 1970; 6: 324-9.
58. Wehner H, Hohn D, Faix-Schade U, Huber H, Walzer P. Glomerular changes in mice with spontaneous hereditary diabetes. Lab Invest 1972; 27: 331-40.
59. Fraser DC, Srivatava J, Woodward CJ, Simpson AE, Jones RB. A molecular investigation of the obese phenotype in the Aston University strain of ob/ob mice and the Japanese Kuo Kondo mice. IntJ Obes Relat Metab Disord 1998; 22: 193-4.
60. Hayase M, Ogawa Y, Katsuura G, Shintaku H, Hosoda K, Nakao K. Regulation of obese gene expression in KK mice and congenic lethal yellow obese KKAy mice. Am J Physiol 1996; 271: E333-9.
61. Reddi AS, Velasco CA, Reddy PR, Khan MY, Camerini-Davalos RA. Diabetic microangiopathy in KK mice. VI. Effect of glycemic control on renal glycoprotein metabolism and established glomerulosclerosis. Exp Mol Pathol 1990; 53: 140-51.
62. Reddi AS, Jyothirmayi GN. Effect of metformin treatment on oral glucose tolerance and glomerulosclerosis in KK mice. Diabetes Metab 1993; 19: 44-51.
63. Lubec B, Aufricht C, Amann G, Kitzmuller E, Hoger H. Arginine reduces kidney collagen accumulation, cross-linking, lipid peroxidation, glycoxidation, kidney weight and albuminuria in the diabetic kk mouse. Nephron 1997; 75: 213-8.
64. Diani RA, Sawada GA, Zhang NY, Wyse BM, Connell CL, Vidmar TJ, Connell MA. The KKAy mouse: a model for the rapid development of glomerular capillary basement membrane thickening. Blood Vessels 1987; 24: 297-303.
65. Ninomiya H, Inomata T, Ogihara K. Glomerular vascular changes in KK-Ay mice with early diabetes: scanning electron microscopy of vascular resin casts. J Vet Med Sci 1998; 60: 103-6.
66. Than S, Ishida H, Inaba M, Fukuba Y, Seino Y, Adachi M, Imura H, Ikehara S. Bone marrow transplantion as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice. J Exp Med 1992; 176: 1233-8.
67. Muto Y, Satoh J, Muto G, Masuda T, Sagara M, Fukuzawa M, Miyaguchi S, Quiang XL, Sakata Y, Nakazawa T, Ikehata F, Toyota T. Effect of long-term treatment with complete Freund's adjuvant on KK-Ay mouse, a model of non-insulin-dependent diabetes mellitus. Clin Immunol Immunopathol 1997; 83: 53-9.
68. Melez KA, Harrison LC, Gilliam GN, Steinberg AD. Diabetes is associated with autoimmunity in the New Zealand obese (NZO) mouse. Diabetes 1980; 29: 835-40.
69. Crofford OB, Davies CK. Growth characteristics, glucose tolerance and insulin sensitivity of New Zealand obese mice. Metabolism 1965; 14: 271-82.
70. Veroni MC, ProiettoJ, Larkins RG. Evolution of insulin resistance in New Zealand obese mice. Diabetes 1991; 40: 1480-7.
71. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 1997; 94: 8878-83.
72. Harrison LC, Itin A. A possible mechanism for insulin resistance and hyperglycemia in NZO mice. Nature 1979; 279: 334-6.
73. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of non-obese diabetic strain of mice. Exp Anim 1980; 29: 1-13.
74. Watanabe Y, Itoh Y, Yoshida F, Koh N, Tamai H, Fukatsu A, Matsuo S, Hotta N, Sakamoto N. Unique glomerular lesion with spontaneous lipid deposition in glomerular capillary lumina in the NON strain of mice. Nephron 1991; 58: 210-8.
75. Karounos DG, Thomas JW. Recognition of common islet antigen by autoantibodies from NOD mice and humans with ID-DM. Diabetes 1990; 39: 1085-90.
76. Zipris D, Crow AR, Delovitch TL. Altered thymic and peripheral T-lymphocyte repertoire preceding onset of diabetes in NOD mice. Diabetes 1991; 40: 429-35.
77. Hellmann B. Studies in the obese-hyperglycemic mice. Ann NY Acad Sci USA 1965; 131: 541-58.
78. Bailey CV, Flatt PR, Radley NS. Effect of high fat and high carbohydrate cafeteria diets on the development of the obese hyperglycemic (ob/ob) syndrome in mice. Nutr Res 1985; 5: 1003-10.
79. Jin T, Nordberg GF, Sehlin J, Leffler P, WuJ. The susceptibility of spontaneously diabetic mice to cadmium-metallothionein nephrotoxicity. Toxicology 1994; 89: 81-90.
80. Chua SC, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, Leibel RL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996; 271: 994-6.
81. Coleman DL. Obesity and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978; 14: 141.
82. Coleman DL, Hummel KP. Hyperinsulinemia in pre-weaning diabetes (db) mice. Diabetologia 1977; 13: 25-6.
83. Gartner K. Glomerular hyperfiltration during the onset of diabetes mellitus in two strains of diabetic mice (C57BL/6J db/db and C57BL/KsJ db/db). Diabetologia 1978; 15: 59-63.
84. Like AA, Lavine RL, Poffenbarger PL, Chick WL. Studies in the diabetic mutant mouse. Am J Pathol 1972; 66: 193-203.
85. Bower G, Brown DM, Steffes MW, Vernier RL, Mauer SM. Studies of the glomerular mesangium and thejuxtaglomerular apparatus in the genetically diabetic mouse. Lab Invest 43: 333-41.
86. Berdanier CD. The BHE strain: an animal model for the study of non-insulin-dependent diabetes mellitus. FASEBJ 1991; 5: 2139-44.
87. Berdanier CD. Metabolic abnormalities in BHE rats. Diabetologia 1974; 10: 691-5.
88. Durand AMA, Fisher M, Adams M. Histology in rats as influenced by age and diet. Arch Pathol 1964; 77: 268-77.
89. Durand AMA, Fisher M, Adams M. The influence of type of dietary carbohydrate: effect on histological findings in two strains of rats. Arch Pathol 1968; 85: 318-24.
90. Marshall MW, Lehmann RP. Influence of heredity on response of inbred rats to diet: I. Differences in body size, food intakes, incidence of spontaneous kidney defects, kidney weights, urine pH and protein. Metabolism 1967; 16: 763-74.
91. Lakshmanan FL, Howe JC, Schuster EM, Barnes RE. Response of two strains of rats to high protein diet containing sucrose or cornstarch. Proc Soc Exp Biol Med 1981; 167: 224-32.
92. Berdanier CD, Johnson B, Hartle DK, Crowell W. Life span is shortened in BHE/cdb rats fed a diet containing 9% menhaiden oil and 1% corn oil. J Nutr 1992; 122: 1309-17.
93. Kimberley AF, Crowell WA, Berdanier CD. Early renal disease in BHE/cdb rats is less in rats fed beef tallow than in rats fed menhaden oil. Proc Soc Exp Biol Med 1993; 203: 163-71.
94. Wickwire K, Porter M, Berdanier CD. Differential hepatic and renal cholesterol levels in diabetes-prone BHE/cdb rats fed menhaden oil or beef tallow. Proc Soc Exp Biol Med 1997; 214: 346-51.
95. Cohen AM, Teitelbaum A, Saliternik R. Genetics and diet as factors in the development of diabetes mellitus. Metabolism 1972; 21: 235-10.
96. Rosenmann E, Cohen AM. Nephropathy in Cohen's diabetic rat characterization and prevention. In: Shafrir E, Renold AE eds. Lessons from animal diabetes. John Libbey, London 1984; 398-401.
97. Rosenthal T, Erlich Y, Rosenmann E, Cohen A. Effects of enalapril, losartan, and verapamil on blood pressure and glucose metabolism in the Cohen-Rosenthal diabetic hypertensive rat Hypertension 1997; 29: 1260-4.
98. Cohen AM, Rosenmann E, Rosenthal T. The Cohen diabetic (non-insulin-dependent) hypertensive rat model. Description of the model and pathologic findings. Am J Hypertens 1993; 6: 989-95.
99. Kawano K, Hiroshima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima fatty (OLETF) strain. Diabetes 1992; 41: 1422-8.
100. Kawano K, Hirashima T, Mori S, Natori T. OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM strain. Diabetes Res Clin Pract 1994; 24: S317-320.
101. Yagi K, Kim S, Wanibuchi H, Yamashita T, Yamamura Y, Iwao H. Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats. Hypertension 1997; 29: 728-35.
102. Kim S, Wanibuchi H, Hamaguchi A, Miura K, Yamanaka S, Iwao H. Angiotensin blockade improves cardiac and renal complications of type II diabetic rats. Hypertension 1997; 30: 1054-61.
103. Fukuzawa Y, Watanabe Y, Inaguma D, Hotta N. Evaluation of glomerular lesion and abnormal urinary findings in OLETF rats resulting from a long-term diabetic state. J Lab Clin Med 1996; 128: 568-78.
104. Mori S, Kawano K, Hirashima T, Natori T. Relationships between diet control and the development of spontaneous type II diabetes and diabetic nephropathy in OLETF rats. Diabetes Res Clin Pract 1996; 33: 145-52.
105. Yamauchi A, Takei I, Makita Z, Nakamoto S, Ohashi N, Kiguchi H, Ishii T, Koike T, Saruta T. Effects of aminoguanidine on serum advanced glycation endproducts, urinary albumin excretion, mesangial expansion, and glomerular basement membrane thickening in Otsuka Long-Evans Tokushima Fatty rats. Diabetes Res Clin Pract 1997; 34: 127-33.
106. Nakamura S, Makita Z, Ishikawa S, Yasumura K, Fujii W, Yanagisawa K, Kawata T, Koike T. Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes 1997; 46: 895-9.
107. Koletsky S. Obese spontaneously hypertensive rats: a model for study of atherosclerosis. Exp Mol Pathol 1973; 19: 53-60.
108. Kahle EB, Butz KG, Chua SC, Kershaw EE, Leibel RL, Fenger TW, Hansen CT, Michaelis OE. The rat corpulent (cp) mutation maps to the same interval on (Pgm1-Glut1) rat chromosome 5 as the fatty (fa) mutation. Obes Res 1997; 5: 142-5.
109. Wu Peng XS, Chua SC Jr, Okada N, Liu SM, Nicolson M, Leibel RL. Phenotype of the obese Koletsky rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat. Diabetes 1997; 46: 513-8.
110. Friedman JE, Ishizuka T, Liu S, Farrell CJ, Bedol D, Koletsky RJ, Kaung H-L, Ernsberger P. Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat AmJ Physiol 1997; 273: E1014-23.
111. Koletsky S. Pathologic findings and laboratory data in an new strain of obese hypertensive rats. Am J Pathol 1975; 80: 129-40.
112. Koletsky RJ, Boccia J, Ernsberger P. Acceleration of renal disease in obese SHR by exacerbation of hypertension. Clin Exp Pharmacol Physiol 1995; (Suppl 1): S254-6.
113. Hansen CT. Two congenic rat strains for nutrition and obesity research. Fed Proc 1983; 42: 537 [Abstract].
114. Michaelis OE, IV, Patrick DH, Hansen CT, Canary JJ, Werner RM, Carswell N. Spontaneous hypertensive/NIH-corpulent rat. An animal model for insulin-independent diabetes mellitus (type II). Am J Pathol 1986; 123: 398-100.
115. Velasquez MT, Kimmel PL, Michaelis OE IV, Carswell N, Abraham A, Bosch JP. Effect of carbohydrate intake on kidney function and structure in SHR/N-cp rats. A new model of NIDDM. Diabetes 1989; 38: 679-85.
116. Velasquez MT, Michaelis OE IV, Szalassi T, Abraham AA, Kimmel PL, Bosch JP. Glomerular hypertrophy and mesangial expansion in the SHR/N-cp rat with type II diabetes: role of type of carbohydrate diet. Kidney Int 1990; 37: 523.
117. Zucker LM. Hereditary obesity in the rat associated with hyperlipemia. Ann NY Acad Sci 1965; 131: 447-58.
118. Kasiske BL, O' Donnell MP, Keane WF. The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension 1992; 19: 110-5.
119. Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ, Caskey CJ, Hess JF. Leptin receptor missense mutation in the fatty Zucker rat [letter]. Nat Genet 1996; 13: 18-9.
120. Ionescu E, Sauter JF, Jeanrenaud B. Abnormal oral glucose tolerance in genetically obese (fa/fa) rats. Am J Physiol 1985; 248: E500-6.
121. Mc Caleb ML, SredyJ. Metabolic abnormalities of the hyperglycemic obese Zucker rat. Metabolism 1992; 41: 522-5.
122. Kasiske BL, Cleary MP, O' Donnell MP, Keane WF. Effects of genetic obesity on renal structure and function in the Zucker rat. J Lab Clin Med 1985; 106: 598-604.
123. Kasiske BL, O'Donnell MP, Cleary MP, Keane WF. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 1988; 33: 667-72.
124. Schmitz PG, O'Donnell MP, Kasiske BL, Katz SA, Keane WF. Renal injury in obese Zucker rats: glomerular hemodynamic alterations and effects of enalapril. Am J Physiol 1992; 263: F596-602.
125. Yoshioka S, Nishino H, Shiraki T, Ikeda K, Koike H, Okuno A, Wada M, Fujiwara T, Horikoshi H. Antihypertensive effects of CS-045 treatment in obese Zucker rats. Metabolism 1993; 42: 75-80.
126. Janssen U, Coimbra T, Grone HJ, Ostendorf T, Schmidt H, Kunter U, FloegeJ. Obese Zucker rats with type II diabetes exhibit early progressive signs of podocyte damage and glomerular hypertrophy. J Am Soc Nephrol 1998; 9: A2541 [Abstract].
127. O'Donnell MP, Kasiske BL, Cleary MP, Keane WF. Effects of genetic obesity on renal structure and function in the obese Zucker rat. II. Micropuncture studies. J Lab Clin Med 1985; 106: 605-10.
128. Michel O, Heudes D, Lamarre I, Masurier C, Lavau M, Bariety J, Chevalier J. Reduction of insulin and triglycerides delays glomerulosclerosis in obese Zucker rats. Kidney Int 1997; 52: 1532-42.
129. Ward KM, MahanJD, Sherman WM. Aerobic training and diabetic nephropathy in the obese Zucker rat. Ann Clin Lab Sci 1994; 24: 266-77.
130. Phillips AO, Baboolal K, Grone HJ, Janssen U, Steadman R, Davies M, WilliamsJD, FloegeJ. Sequential metabolic and renal changes in non-obese, normotensive rat model of type II diabetes. J Am Soc Nephrol 1998; 9: A3265 [Abstract].
131. Grone HJ, Walli A, Grone E, Niedmann P, ThieryJ, Seidel D, Helmchen U. Induction of glomerulosclerosis by dietary lipids. A functional and morphologic study in the rat. Lab Invest 1989; 60: 433-46.
132. Joles JA, Kriz W, Janssen U, Koomans HA, Floege J. Early signs of podocyte but not mesangial cell injury in hyperlipidemic female analbuminemic rats. J Am Soc Nephrol 1997; 8: A619 [Abstract].
133. Wheeler DC, Nair DR, Persaud JW, Jeremy JY, Chappell ME, Varghese Z, Moorhead JF. Effects of dietary fatty acids in an animal model of focal glomerulosclerosis. Kidney Int 1991; 39: 930-7.
134. Magil AB, Fröhlich JJ. Monocytes and macrophages in focal glomerulosclerosis in Zucker rats. Nephron 1991; 59: 131-8.
135. Lavaud S, Michelle O, Sassy-Prigent C, Heudes D, Bazin R, Bariety J, Chevalier J. Early influx of glomerular macrophages precedes glomerulosclerosis on the obese Zucker rat model. J Am Soc Nephrol 1996; 7: 2604-15.
136. Park YS, Guijarro C, Kim Y, Massy ZA, Kasiske BL, Keane WF, O'Donnell MP. Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats. Am J Kidney Dis 1998; 31: 190-4.
137. Guijarro C, Kasiske BL, Kim Y, O'Donnell MP, Lee HS, Keane WF. Early glomerular changes in rats with dietary-induced hypercholesterolemia. Am J Kidney Dis 1995; 26: 152-61.
138. Kasiske BL, O'Donnell MP, Schmitz PG, Kim Y, Keane WF. Renal Injury of diet-induced hypercholesterolinemia in rats. Kidney Int 1990; 37: 880-91.
139. Kim SY, Guijarro C, O'Donnell MP, Kasiske BL, Kim Y, Keane WF. Human mesangial cell production of monocyte chemoattractant protein-1: modulation by lovastatin. Kidney Int 1995; 48: 363-71.
140. O'Donnell MP, Kasiske BL, Kim Y, Schmitz PG, Keane WF. Lovastatin retards the progression of established glomerular disease in obese Zucker rats. Am J Kidney Dis 1993; 22: 83-9.
141. Kasiske BL, O'Donnell MP, Lee H, Kim Y, Keane WF. Impact of dietary fally acid supplementation on renal injury in obese Zucker rats. Kidney Int 1991; 39: 1125-34.
142. FloegeJ, Alpers CE, Sage EH, Pritzl P, Gordon K, Johnson RJ, Couser WG. Markers of complement-dependenl and complement-independent glomerular visceral epithelial cell injury in vivo. Expression of antiadhesive proteins and cytoscheletal changes. Lab Invest 1992; 67: 486-97.
143. Grone HJ, Weber K, Grone E, Helmchen U, Osborne M. Co-expression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney. Am J Pathol 1987; 129: 1-8.
144. Alpers CE, Hudkins KL, Floege J, Johnson RJ. Human renal cortical interstitial cells with some fealures of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J Am Soc Nephrol 1994; 5: 201-9.
145. Peterson RG, Shaw WN, Neel M-A, Little LA, Eichberg J. Zucker diabetic fatty rats as a model for non-insulin-dependent diabetes mellitus. ILAR News 1990; 32: 16-9.
146. Vora JP, Zimsen SM, Houghton DC, Anderson S. Evolution of metabolic and renal changes in the ZDF/Drt-fa rat model of type II diabetes. J Am Soc Nephrol 1996; 7: 113-7.
147. Ikeda H, Shino A, Matsuo T, Iwatsuka H, Suzuoki Z. A new genetically obese-hyperglycemic rat (Wistar fatty). Diabetes 1981; 30: 1045-50.
148. Yamakawa T, Tanaka S, Tamura K, Isoda F, Ukawa K, Yamakura Y, Takanashi Y, Kiuchi Y, Umemura S, Ishiuu M, et al. Wistar fatty rat is obese and spontaneously hypertensive. Hypertension 1995; 25: 146-50.
149. Suzuki H, Ikenaga H, Hayashida T, Otsuka K, Kanno Y, Ohno Y, Ikeda H, Saruta T. Sodium balance and hypertension in obese and fatty rats. Kidney Int 1996; 55: 150-3.
150. Matsuo T, Ikeda H, Iwatsuka H, Suzuoki Z. Role of sucrose diet in the development of hyperglycemia in female Wistar fatty rats. In: Shafrir E, Renold AE, eds. Lessons from Animal diabetes. London: John Libbey 1984; 261-4.
151. Kava RA, West DB, Lukasik VA, Greenwood MRC. Sexual dimorphism of hyperglycemia and glucose tolerance in Wistar fatty rats. Diabetes 1989; 38: 159-63.
152. Diani AR, Ledbetter SR, Sawada GA, Copeland EJ, Wyse BM, Hannah BA, Peterson T. Structural and functional evidence of diabetic nephropathy in the Wistar fatty diabetic rat. In: Shafrir E and Renold AE, eds. Frontiers in diabetes research. Lessons from animal diabetes II. London: John Libbey 1988; 535-41.
153. Matsui H, Suzuki M, Tsukuda R, Iida K, Miyasaka M, Ikeda H. Expression of ICAM-1 on glomeruli is associated with progression of diabetic nephropathy in a genetically obese diabetic rat, Wistar fatty. Diabetes Res Clin Pract 1996; 32: 1-9.
154. Goto Y, Suzuki K, Sasaki M, Ono T, Abe S. GK rats as a model of nonobese, non-insulin-dependent diabetes. Selective breeding over 35 generations. In: Shafrir E, Renold AE (eds) Frontiers in Diabetes Research. Lessons from animal diabetes II. London: John Libbey 1988; 301-3.
155. Movassat J, Saulnier C, Serradas P, Portha B. Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat. Diabetologia 1997; 40: 916-25.
156. Ostenson CG, Khan A, Abdel-Halim SM, Guenifi A, Suzuki K, Goto Y, Efendie S. Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat. Diabetologia 1993; 36: 3-8.
157. Picarel-Blanchot F, Berthelier C, Bailbe D, Portha B. Impaired insulin secretion and excessive hepatic glucose production are both early events in the diabetic GK rat. Am J Physiol 1996; 271: E755-62.
158. Bisbis S, Bailbe D, Tormo MA, Picarel-Blanchot F, Derouet M, Simon J, Portha B. Insulin resistance in the GK rat: decreased receptor number but normal kinase activitiy in liver. Am J Physiol 1993; 265: E807-13.
159. Yagihashi S, Goto Y, Kakizaki M, Kaseda N. Thickening of glomerular basement membrane in spontaneously diabetic rats. Diabetologia 1978; 15: 309-12.
160. Osterby R, Gundersen HJG. Glomerular size and structure in diabetes mellitus. I. Early abnormalities. Diabetologia 1975; 11: 225-9.